Document is current
Any future updates will be listed below
-
Authors
Oberländer, Kristin
Pruunsild, Priit https://orcid.org/0000-0001-6823-6683
Koch, Philipp https://orcid.org/0000-0003-2825-7943
Yan, Jing
Szafranski, Karol https://orcid.org/0000-0001-6391-1766
Bading, Hilmar https://orcid.org/0000-0003-0258-4348
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR 2289, BA1007/20-1)
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 16 October 2025
First Online: 3 December 2025
Competing interests
: H.B. and J.Y. are named inventors of the patent application for a novel class of neuroprotectants (PCT/EP2018/078577); H.B. is the founder of FundaMental Pharma GmbH, Heidelberg, Germany, which licenses FP802. H.B. and J.Y. are shareholders of FundaMental Pharma GmbH. Other authors report no competing interests.
